Hannah Flynn

Medicines and Healthcare Products Regulatory Agency in the United Kingdom has recently approved the use of anastrozole, an aromatase inhibitor, for the reduction of breast cancer risk in women after menopause. How does it work?

New research in mice suggests that changes in energy metabolism at cellular level precede the onset of Alzheimer’s disease-like symptoms.

A short course of induction chemotherapy may be able to reduce relapse and death rates from cervical cancer by 39%, a new trial indicates.

Recent evidence suggests that low serotonin levels may play a role in gut inflammation, which, in turn, may mediate brain fog symptoms in long COVID.

Research from Sweden concludes that women with obesity who opt for bariatric surgery could also lower their risk for blood cancer.

New research conducted in mice offers fresh insights as to how the hormone melatonin may influence memory formation.

Alzheimer’s research has been at the focus of various controversies over the past year. What happened, and what steps might scientists have to take next?

A new study offers insight into why excess weight can increase the risk of endometrial cancer. Researchers say it could be explained by two hormones.

The phenomenon of immune imprinting may influence the evolution of future COVID-19 vaccines, but why and how? Medical News Today asked the experts.

Two hundred scientists have contributed to the largest MRI study that charts the changes occurring in the human brain from birth to death.